blocking immune system

ALS TDI investigators have found that disrupting part of the immune system slows disease progression in mice with an ALS-like disease

posted on March 29, 2010 - 2:22am
Blocking a key molecular pathway that the body uses to amplify an immune response has been found to delay disease onset and extend survival in mice with a disease that mimics human amyotrophic lateral sclerosis (ALS), say researchers at the MDA-supported ALS Therapy Development Institute (ALS TDI) in Cambridge, Mass.

New content is being added every day. Please check back again.